Market Leaders and Consumer Data
Global skincare market research from Euromonitor International identifies CeraVe, La Roche-Posay, and Neutrogena as the top three cream brands by sales volume in 2024. CeraVe's Moisturizing Cream leads in the drugstore segment, driven by dermatologist recommendations and pharmacy distribution. La Roche-Posay's Cicaplast Baume B5 ranks first in the sensitive skin category across European and North American markets. These brands collectively hold over 30 percent of the global facial moisturizer market share. The data reflects multi-channel retail tracking from January to December 2024, with year-over-year growth rates of 4 to 7 percent for the top three brands.
Consumer testing panels conducted by the American Academy of Dermatology show that CeraVe and La Roche-Posay formulations score highest for ingredient safety and barrier repair efficacy. The best cream products in 2025 share ceramide-rich formulations, fragrance-free compositions, and non-comedogenic labeling. Sephora and Ulta Beauty's 2024 bestseller lists confirm CeraVe Moisturizing Cream as the number one moisturizer in the United States. The product's price point, typically under 18 dollars per 16-ounce jar, contributes to its accessibility and repeat purchase rate.
Corporate Ownership and Financial Performance
CeraVe is owned by L'Oréal, which acquired the brand in 2017. L'Oréal's active cosmetics division reported 5.2 billion euros in revenue for fiscal year 2024, with CeraVe as a key growth driver. La Roche-Posay operates as a subsidiary of L'Oréal's luxury division, generating consistent double-digit annual growth in the medical skincare segment. Neutrogena is owned by Johnson & Johnson, which reported 15.6 billion dollars in consumer health revenue for 2024. The parent company's 2024 annual report highlights Neutrogena Hydro Boost as the highest-selling cream product in the Johnson & Johnson portfolio.
Private-label and direct-to-consumer cream brands have gained market share through online channels. Drunk Elephant, owned by Shiseido, reported a 12 percent increase in North American cream sales in 2024. The brand's T.L.C. Framboos Glycolic Night Cream ranks among the top five premium moisturizers by Sephora sales volume. These brands invest heavily in clinical testing and dermatologist partnerships, which directly influences consumer trust and repeat purchases.
Regulatory and Ingredient Standards
The U.S. Food and Drug Administration classifies moisturizing creams as cosmetic products, not drugs, unless they make specific treatment claims. The FDA's 2024 enforcement priorities focus on mislabeled ingredients and unapproved active substances in over-the-counter skincare. The European Commission's CosIng database lists ceramides, hyaluronic acid, and niacinamide as the most frequently used active ingredients in top-rated cream formulations. The EU's Cosmetics Regulation (EC) No 1223/2009 requires safety assessments and ingredient labeling compliance for all products sold in the European Economic Area.
The Securities and Exchange Commission filings for L'Oréal and Johnson & Johnson disclose R&D spending on skincare innovation. L'Oréal's 2024 annual report shows 3.1 billion euros in total research and development expenditure, with a significant portion allocated to cream and moisturizer formulations. Johnson & Johnson's 2024 10-K filing highlights investment in ceramide technology and microbiome-friendly formulations. Investors tracking the best cream brands monitor these R&D figures as indicators of long-term product pipeline strength and market competitiveness.